haloperidol has been researched along with Cardiomyopathies, Primary in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Remijnse, PL | 1 |
Eeckhout, AM | 1 |
van Guldener, C | 1 |
Hull, BE | 1 |
Lockwood, TD | 1 |
2 other studies available for haloperidol and Cardiomyopathies, Primary
Article | Year |
---|---|
[Sudden death following a single oral administration of haloperidol].
Topics: Administration, Oral; Adult; Antipsychotic Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death, Su | 2002 |
Toxic cardiomyopathy: the effect of antipsychotic-antidepressant drugs and calcium on myocardial protein degradation and structural integrity.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Calcium; Cardiomyopathies; Haloperidol; Muscle | 1986 |